Yao Jie, Zhang Tao, Ren Jinghua, Yu Minxia, Wu Gang
Cancer Center, Union Hospital, Huazhong University of Sciences and Technology, Wuhan 430023, Hubei Province, P.R. China.
Oncol Rep. 2009 Oct;22(4):781-7. doi: 10.3892/or_00000500.
The stem cell marker CD133/prominin-1, is a pentaspan membrane glycoprotein, which has also been identified as a cancer stem cell (CSC) marker in several solid tumor types, including those of the prostate, liver, colon and brain. The function of CD133 in these tumors is still unknown. We hypothesize that the function of CD133 is correlated with the characteristics of the CD133+ CSCs and may affect the growth of the tumor cell population as a whole. In this study we used antisense oligodeoxynucleotides (ASODNs) of CD133 to knock-down (KD) CD133 expression. We showed that the CD133-KD inhibited proliferation of U251 human glioma cells, decreased the colony forming ability and altered the cell cycle distribution in Huh-7 human hepatocellular carcinoma cells. Our data suggest that CD133 may play an important functional role in the growth of these tumor cells. Moreover, this study also showed that prominin-2, another protein in the same family as CD133/prominin-1, may not have a similar function.
干细胞标志物CD133/普罗明蛋白-1是一种五跨膜糖蛋白,在包括前列腺、肝脏、结肠和脑肿瘤在内的多种实体瘤类型中也被鉴定为癌症干细胞(CSC)标志物。CD133在这些肿瘤中的功能仍不清楚。我们推测CD133的功能与CD133+癌症干细胞的特性相关,并可能影响整个肿瘤细胞群体的生长。在本研究中,我们使用CD133的反义寡脱氧核苷酸(ASODN)来敲低(KD)CD133的表达。我们发现,CD133基因敲低抑制了U251人胶质瘤细胞的增殖,降低了Huh-7人肝癌细胞的集落形成能力,并改变了细胞周期分布。我们的数据表明,CD133可能在这些肿瘤细胞的生长中发挥重要的功能作用。此外,本研究还表明,普罗明蛋白-2,与CD133/普罗明蛋白-1同一家族的另一种蛋白,可能不具有类似功能。